| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-06 | 2025-02-27 | 2024-02-27 | 2023-03-08 | 2022-03-04 | 2020-12-31 | 2019-12-31 |
| Revenue | 218.9 | 209.4 | 187.1 | 141.8 | 94.42 | 57.37 | 39.42 |
| Cost of Revenue | 44.05 | 41.09 | 35.18 | 27.52 | 16.89 | 12.47 | 7.63 |
| Gross Profit | 174.8 | 168.3 | 151.9 | 114.3 | 77.53 | 44.9 | 31.79 |
| Operating Expenses | 223.3 | 224 | 203.4 | 149.2 | 94.04 | 44.04 | 35.32 |
| Research & Development | 20.95 | 20.59 | 15.44 | 13.58 | 10.2 | 5.85 | 5.07 |
| Selling, General and Administrative | 201.3 | 203.4 | 187.9 | 137.6 | 83.84 | 38.19 | 30.25 |
| Other Operating Expenses | 1 | 0 | 0 | -1.99 | 0 | 0 | 0 |
| Operating Income | -48.44 | -55.69 | -51.43 | -34.84 | -16.51 | 0.855 | -3.54 |
| Net Non-Operating Interest | -2.13 | -0.379 | 1.56 | -3.08 | -4.04 | -4.52 | -0.73 |
| Interest Income | 3.15 | 4.88 | 6.73 | 1.31 | 0.018 | 0 | 0.111 |
| Interest Expense | 5.28 | 5.26 | 5.17 | 4.4 | 4.06 | 4.52 | 0.841 |
| Equity & Other Income/(Expense) | 0.462 | 0.324 | 0.342 | -4.89 | 0 | 0 | 0 |
| Income Before Tax | -50.11 | -55.74 | -49.53 | -42.81 | -20.55 | -3.67 | -4.26 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -50.11 | -55.74 | -49.53 | -42.81 | -20.55 | -3.67 | -4.26 |
| Depreciation and Amortization | 10.05 | 8.42 | 5.35 | 2.13 | 0.685 | 1.21 | 0.793 |
| EBITDA | -38.38 | -47.27 | -46.08 | -32.71 | -15.82 | 2.06 | -2.74 |
| Earnings Per Share (EPS) | -0.798 | -0.9 | -0.81 | -0.77 | -0.38 | -0.084 | -0.1 |
| Diluted Earnings Per Share | -0.798 | -0.9 | -0.81 | -0.77 | -0.38 | -0.084 | -0.1 |
| Weighted Average Shares Outstanding | 63.52 | 62.11 | 60.85 | 55.28 | 54.18 | 51.17 | 51.17 |
| Diluted Weighted Average Shares Outstanding | 63.52 | 62.11 | 60.85 | 55.28 | 54.18 | 51.17 | 51.17 |
